NAGE June 26 earnings expected move?

For "NAGE June 26 earnings historical move size historically": across 2 resolved past events on file, NAGE saw a median absolute move of ~21.9% to the outcome date (backward-looking only). See the historical catalyst schedule on Scouter for NAGE (past outcomes only; forward bull/bear targets unlock with a Starter or Premium free trial).

NAGE typical earnings move 4 percent?

For "NAGE typical earnings move 4 percent": across 2 resolved past events on file, NAGE saw a median absolute move of ~21.9% to the outcome date (backward-looking only). See the historical catalyst schedule on Scouter for NAGE (past outcomes only; forward bull/bear targets unlock with a Starter or Premium free trial).

NAGE (Niagen Bioscience Inc) — Stock Analysis, Catalysts & AI Research

Niagen Bioscience Inc

$3.04

Health CareBiotechnology

The Read: 8% move when stabilizing EPS halted net income declines and share repurchases supported the stock, while typical earnings reactions near 4% occurred when modest beats and sales growth lacked new clinical catalysts.

NAGE

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Scouting Reports

The IPO Market Thaw and the Return to Active Management

Jun 2, 2026

The long-dormant initial public offering market is officially thawing. The maker of the popular Claude AI chatbot is preparing a landmark public listing, a highly anticipated move poised to redefine W

Niagen Bioscience Inc

$3.04

Health CareBiotechnology

NAGE

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Scouting Reports

The IPO Market Thaw and the Return to Active Management

Jun 2, 2026

Start your free trial to unlock active Expected Moves for NAGE

Expected Moves

Niagen Bioscience Inc

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Scouting Reports

The IPO Market Thaw and the Return to Active Management

Start your free trial to unlock active Expected Moves for NAGE

Expected Moves

Niagen Bioscience Inc

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Scouting Reports

The IPO Market Thaw and the Return to Active Management